Boehringer Ingelheim International GmbH Boehringer Ingelheim invests in innovative peptide research and collaborates on GLP-1 related compounds, focusing on improving treatment outcomes for metabolic disorders
Below, we discuss the effects of MedDiet on SCFAs, BAs, TMAO, and LPS, and the mechanisms by which the MedDiet could potentially alter the gut microbiota to combat obesity
Your healthcare team can assess whether alternative medications might be appropriate
Front Endocrinol 13:1089918 Gu X-Y, Yang J-L, Lai R, Zhou Z-J, Tang D, Hu L et al (2025) Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives
Unlike synthetic drugs that force a specific response, peptides simply enhance the signaling pathways your cells already use
Each numbered reference above corresponds to the inline citation marks (e.g